119134
Adenosine 5′-O-(2-Thiodiphosphate), Trilithium Salt
A P2-purinergic receptor agonist that acts as a potent insulin secretagogue.
别名:
Adenosine 5′-O-(2-Thiodiphosphate), Trilithium Salt, ADP-β-S, 3Li
InChI
1S/C10H15N5O9P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(23-10)1-22-25(18,19)24-26(20,21)27/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H2,11,12,13)(H2,20,21,27)/t4-,6-,7-,10-/m1/s1
InChI key
HCIKUKNAJRJFOW-KQYNXXCUSA-N
assay
≥80% (HPLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, desiccated (hygroscopic)
impurities
≤10% ADP
color
white
solubility
water: 20 mg/mL
shipped in
wet ice
storage temp.
−20°C
Quality Level
General description
A P2-purinergic receptor agonist that acts as a potent insulin secretagogue. Substrate and inhibitor of ADP-dependent enzyme systems.
Substrate and inhibitor of ADP-dependent enzyme systems. A P2-purinergic agonist that acts as a potent insulin secretagogue.
Biochem/physiol Actions
Cell permeable: no
Primary Target
A P2-purinergic receptor agonist
A P2-purinergic receptor agonist
Product does not compete with ATP.
Reversible: no
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Other Notes
Shalev, M., et al. 1999. J. Urol. 161, 955.
Hillaire-Buys, D., et al. 1993. Br. J. Pharmacol. 109, 183.
Bertrand, G., et al. 1991. Br. J. Pharmacol.102, 627.
Eckstein, F., and Goody, R.S. 1976. Biochemistry15, 1685.
Hillaire-Buys, D., et al. 1993. Br. J. Pharmacol. 109, 183.
Bertrand, G., et al. 1991. Br. J. Pharmacol.102, 627.
Eckstein, F., and Goody, R.S. 1976. Biochemistry15, 1685.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持